Astrotech (ASTC) Prices 7.826M Share Upsized Common Offering at $2.30/Sh

Pre-Open Stock Movers 10/21: (ASTC) (SNAP) (CALX) Higher; (GSX) (NAVI) (NFLX) Lower (more...)

Today's Pre-Open Stock Movers

Astrotech Corporations (NASDAQ: ASTC) 177% HIGHER; subsidiary, BreathTech Corporation announced today that it has signed a joint development agreement (JDA) with Cleveland Clinic to explore leveraging Astrotechs BreathTest-1000 mass spectrometer to rapidly screen for COVID-19 or related indicators. The goal of the agreement is to develop a non-invasive device that will use breath samples to identify COVID-19 strains, with the potential to provide a low-cost, self-service screening option that could be deployed on a large-scale.

Snap (NYSE: SNAP)... More

After-Hours Stock Movers 10/20: (ASTC) (SNAP) (PRTA) Higher; (NAVI) (NFLX) (APTX) Lower (more...)

Today's After-Hours Movers

Astrotech Corporations (NASDAQ: ASTC) 77% HIGHER; subsidiary, BreathTech Corporation announced today that it has signed a joint development agreement (JDA) with Cleveland Clinic to explore leveraging Astrotechs BreathTest-1000 mass spectrometer to rapidly screen for COVID-19 or related indicators. The goal of the agreement is to develop a non-invasive device that will use breath samples to identify COVID-19 strains, with the potential to provide a low-cost, self-service screening option that could be deployed on a large-scale.

Snap (NYSE: SNAP)... More

Astrotech (ASTC) Surges on Development Deal with Cleveland Clinic for Rapid COVID-19 Breath Test

Astrotech (NASDAQ: ASTC) is gaining 77% after-hours Tuesday after the company signed a joint development agreement (JDA) with Cleveland Clinic to explore leveraging Astrotechs BreathTest-1000 mass spectrometer to rapidly screen for COVID-19 or related indicators. The goal of the agreement is to develop a... More

Astrotech (ASTC) Subsidiary and Cleveland Clinic Partner to Develop a Rapid COVID-19 Breath Test

Astrotech Corporations (NASDAQ: ASTC) subsidiary, BreathTech Corporation announced today that it has signed a joint development agreement (JDA) with Cleveland Clinic to explore leveraging Astrotechs BreathTest-1000 mass spectrometer to rapidly screen for COVID-19 or related indicators. The goal of the agreement is to develop a non-invasive device that will use breath samples to identify COVID-19 strains, with the potential to provide a low-cost, self-service screening option that could be deployed on a large-scale.

Raed Dweik, M.D., Chairman of Cleveland Clinics Respiratory Institute, will lead the Cleveland Clinic... More